Stock Events

Stock Events

Lantern Pharma (LTRN) Q2 2025 Earnings

15MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.56

-0.51

-0.47

-0.42

Details

Expected EPS

-0.49

Actual EPS

-0.42

Surprise EPS

0.07

Surprise Percent

+14.29%

Description

Lantern Pharma (LTRN) has reported earnings of -0.42 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.